Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Vidal-Puig

Showing results (1-10 of 60) with videos related to

Pageof 6
Sort By:
Diabetes, Obesity & Metabolism|July 9, 2002
PPARgamma and the thiazolidinediones: molecular basis for a treatment of 'Syndrome X'?C Sewter, A Vidal-Puig
Nature|September 15, 2001
Metabolism. Controlling the glucose factoryA Vidal-Puig, S O'Rahilly
Journal of Internal Medicine|August 25, 2018
"Obesity-associated metabolic complications, the second wave of the tsunami" 14th Key SymposiumA Vidal-Puig, S Enerback
Molecular Medicine Today|August 12, 2000
Obesity and diabetes: an avalanche of new informationA Vidal-Puig, S O'Rahilly
Minerva Medica|February 19, 2002
Mitochondrial uncoupling proteins in human physiology and diseaseT Hagen, A Vidal-Puig
Medicina Clinica|June 14, 1997
[Molecular genetics of non insulin dependent diabetes mellitus]A Vidal-Puig, C Bjørbaek
Clinical Endocrinology|October 27, 2001
Resistin: a new link between obesity and insulin resistance?A Vidal-Puig, S O'Rahilly
Biochimica Et Biophysica Acta|January 5, 2010
Special issue on lipotoxicityA Vidal-Puig, Roger H Unger
Biotechniques|September 1, 1994
Comparative sensitivity of alternative single-strand conformation polymorphism (SSCP) methodsA Vidal-Puig, D E Moller
Transplantation Proceedings|December 1, 1994
Tolerance to peripheral tissue is transient and maintained by tissue-specific class I expressionA Vidal-Puig, D L Faustman
Pageof 6

Showing results (1-10 of 60) with videos related to

Sort By:
Pageof 6
Diabetes, Obesity & Metabolism|July 9, 2002
PPARgamma and the thiazolidinediones: molecular basis for a treatment of 'Syndrome X'?C Sewter, A Vidal-Puig
Nature|September 15, 2001
Metabolism. Controlling the glucose factoryA Vidal-Puig, S O'Rahilly
Journal of Internal Medicine|August 25, 2018
"Obesity-associated metabolic complications, the second wave of the tsunami" 14th Key SymposiumA Vidal-Puig, S Enerback
Molecular Medicine Today|August 12, 2000
Obesity and diabetes: an avalanche of new informationA Vidal-Puig, S O'Rahilly
Minerva Medica|February 19, 2002
Mitochondrial uncoupling proteins in human physiology and diseaseT Hagen, A Vidal-Puig
Medicina Clinica|June 14, 1997
[Molecular genetics of non insulin dependent diabetes mellitus]A Vidal-Puig, C Bjørbaek
Clinical Endocrinology|October 27, 2001
Resistin: a new link between obesity and insulin resistance?A Vidal-Puig, S O'Rahilly
Biochimica Et Biophysica Acta|January 5, 2010
Special issue on lipotoxicityA Vidal-Puig, Roger H Unger
Biotechniques|September 1, 1994
Comparative sensitivity of alternative single-strand conformation polymorphism (SSCP) methodsA Vidal-Puig, D E Moller
Transplantation Proceedings|December 1, 1994
Tolerance to peripheral tissue is transient and maintained by tissue-specific class I expressionA Vidal-Puig, D L Faustman
Pageof 6